Research output per year
Research output per year
Fingerprint
Dive into the research topics where Richard Greil is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
-
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd
Singer, C. F., Jahn, S. W., Hlauschek, D., Heber, U. M., Mang-Manger, C., Egle, D., Balic, M., Pichler, A., Pfeiler, G., Kacerovsky-Strobl, S., Suppan, C., Ritter, M., Petru, E., Greil, R. (Co-author), Bago-Horvath, Z., Deutschmann, C., Steger, G. G., Seifert, M., Fitzal, F. & Bartsch, R. & 10 others, , Apr 2025, In: CANCER COMMUNICATIONS. 45, 4, p. 428-432 5 p.Research output: Contribution to journal › Letter to the editor › peer-review
Open Access -
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
Rinnerthaler, G. (First author), Egle, D., Bartsch, R., Schmitt, C. A., Petzer, A., Balic, M., Petru, E., Denison, U., Singer, C. F., Bjelic-Radisic, V., Gampenrieder, S. P. (Co-author), Knauer, M., Sotlar, K. (Co-author), Brunner, C. (Co-author), Posch, F., Hlauschek, D., Sölkner, L., Bago-Horvath, Z., Filipits, M. & Gili, M. & 10 others, , 16 Jan 2025, In: NATURE CANCER. 13 p.Research output: Contribution to journal › Original Article › peer-review
Open Access -
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA
Shadman, M., Munir, T., Robak, T., Brown, J. R., Kahl, B. S., Ghia, P., Giannopoulos, K., Simkovic, M., Osterborg, A., Laurenti, L., Walker, P. A., Opat, S. S., Ciepluch, H., Greil, R. (Co-author), Hanna, M., Tani, M., Trneny, M., Brander, D., Flinn, I. W. & Grosicki, S. & 13 others, , 1 Mar 2025, In: Journal of Clinical Oncology. 43, 7, 15 p.Research output: Contribution to journal › Original Article › peer-review
Open Access2 Citations (Web of Science) -
Addition of the MUC-1 vaccine tecemotide to neoadjuvant systemic therapy for patients with early breast cancer: Survival results from the prospective randomized ABCSG 34 trial
Singer, C. F., Hlauschek, D., Pfeiler, G., Egle, D., Bartsch, R., Suppan, C., Pichler, A., Petru, E., Greil, R., Rudas, M., Seifert, M., Petzer, A., Fitzal, F., Bago-Horvath, Z., Filipits, M., Soelkner, L., Fesl, C. & Gnant, M., 1 Jun 2024, In: Journal of Clinical Oncology. 42, 16, 1 p.Research output: Contribution to journal › Abstract (Journal) › peer-review
-
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Dorff, T., Horvath, L. G., Autio, K., Bernard-Tessier, A., Rettig, M. B., Machiels, J.-P., Bilen, M. A., Lolkema, M. P., Adra, N., Rottey, S., Greil, R. (Co-author), Matsubara, N., Tan, D. S. W., Wong, A., Uemura, H., Lemech, C., Meran, J., Yu, Y., Minocha, M. & Mccomb, M. & 8 others, , 15 Apr 2024, In: CLINICAL CANCER RESEARCH . 30, 8, p. 1488-1500 13 p.Research output: Contribution to journal › Original Article › peer-review
10 Citations (Web of Science)
Projects
- 14 Finished
-
The effect of high tone therapy in chemotherapy-induced peripheral neuropathy (HIT-CIPN)
Schaffler-Schaden, D. (Further contributor), Johansson, T. (CoPI), Gampenrieder, S. P. (CoPI), Rinnerthaler, G. (Further contributor), Lampl, K. (Further contributor), Greil, R. (Further contributor), Flamm, M. (Further contributor), Dengg, N. (Further contributor), Sassmann, R. (PI), Herfert, J. (Further contributor), Niebauer, J. (Further contributor), Rieder, F. (Further contributor) & Kienberger, Y. (Further contributor)
1/01/19 → 1/01/21
Project: Research
-
Immunity in Cancer and Allergy (4. Laufzeit) - PhD Projektteil Greil
Greil, R. (PI)
1/01/18 → 1/01/21
Project: Research
-
Analysis of circulating cell-free DNA to monitor tumor burden and treatment in head and neck cancer
Gampenrieder, S. P. (Further contributor), Hufnagl, C. (PI), Melchardt, T. (Further contributor), Magnes, T. (Further contributor), Rinnerthaler, G. (Further contributor), Egle, A. (Further contributor), Leisch, M. (Further contributor), Weiss, L. (Further contributor) & Greil, R. (Further contributor)
1/04/17 → 1/04/18
Project: Research
-
Immunity in Cancer and Allergy (3. Laufzeit) - PhD Projektteil Greil
Greil, R. (PI)
1/01/15 → 1/01/18
Project: Research
-
Predicitive targets for response and tolerability to immunomodulatory therapy in CLL
Greil, R. (PI)
1/07/12 → 1/07/15
Project: Research
Prizes
Activities
-
CLL Annual International Workshop 2017
Greil, R. (Organiser) & Hartmann, T. (Organiser)
1 Apr 2017Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA
-
CCS Workshop 2017
Hartmann, T. (Organiser) & Greil, R. (Organiser)
31 Mar 2017Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA
-
AGMT Investigatormeeting 2017
Greil, R. (Organiser)
13 Jan 2017Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA
-
AGMT Jahresmeeting Generalversammlung 2016
Greil, R. (Organiser)
2 Sept 2016 → 3 Sept 2016Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA
-
CLL Annual International Workshop
Hartmann, T. (Organiser) & Greil, R. (Organiser)
9 Apr 2016Activity: Participating in or organising an event › Organising a conference, workshop, ... › participants: NA